Is the survival rate of lung cancer targeted therapy high

Update Date: Source: Network

summary

My aunt got lung cancer a few years ago, and it has become serious recently. I heard that targeted therapy for lung cancer has good effect. I was worried that it would have adverse effects on my aunt. I went to the hospital to consult experts and wanted to know whether the survival rate of targeted therapy for lung cancer is high or not. The doctor popularized the relevant knowledge to me. Now let me talk about the survival rate of lung cancer targeted therapy.

Is the survival rate of lung cancer targeted therapy high

First: it was learned at the 10-year high-end summit of targeted therapy for non-small cell lung cancer that in the past decade, targeted therapy has significantly increased the median survival time of patients with advanced lung cancer by 2.4 times, from 14.1 months to 33.5 months, and the five-year survival rate has increased from 8% to 18%.

Second: targeted therapy is at the molecular level, aiming at the already clear cancer targets, so that tumor cells die specifically without affecting normal cell tissues. Patients can obtain good therapeutic effect and greatly improve their quality of life.

Third, gene testing must be done before targeted therapy. In 2014, more than 100 hospitals in China have established in-hospital EGFR gene mutation detection platform, which provides a guarantee for individualized treatment and clinical research of lung cancer. At the same time, circulating tumor DNA (ctDNA) obtained from blood (plasma) samples can also be used as a supplementary method for EGFR detection. Through the investigation of eight cities, such as Beijing, Shanghai and Guangzhou, it is found that the detection rate of EGFR gene in lung cancer is 51%, from the national point of view, the detection rate is only 27%.

matters needing attention

According to the actual situation of patients, there are many factors that will affect the effect of treatment. Patients should have an optimistic attitude and actively cooperate with the treatment. Before receiving a treatment, they should ask the doctor. They can't treat blindly, which not only has no effect, but also increases the burden of the body and makes the condition worse. The survival rate of targeted therapy for lung cancer is generally five years or more.